A Randomized, Double-blind, Multicenter, Phase III Study to Evaluate the Efficacy and Safety of Combination of Fimasartan/Rosuvastatin in Comparison to Each Component Administered Alone in Patients With Essential Hypertension and Dyslipidemia

A phase 3 trial registered on ClinicalTrials.gov. The registry status is completed. It enrolled 140 participants.

Also called NCT02166814

  • Study
  • In this atlas

Overview

Design
Interventional study; randomized; triple masking; primary purpose treatment
Phase
Phase 3
Enrolled
  • 140 participants (enrolled count) (from the registry)
Sponsor
Registry
  • NCT NCT02166814
Other papers using this trial's data
  • The efficacy and safety of co-administration of fimasartan and rosuvastatin to patients with hypertension and dyslipidemia BMC pharmacology & toxicology, 2017-01-05 DOI, PubMed 28057081, PMC5217661 In the PMC Open Access subset under CC BY.

Courtesy of the U.S. National Library of Medicine.

Start date
(registry gives no type) (from the registry)
Primary completion
(actual) (from the registry)
Completion
(actual) (from the registry)
Countries
South Korea (from the registry)
Registry status
  • Completed (from the registry)

Technical summary

Registry record NCT02166814. Randomized; triple masking; primary purpose treatment. Start 2014-08 (registry gives no type); primary completion 2015-09 (actual). Results not posted.

The registry's words

Labels as the registry gives them, not rewritten.

Brief title
A Randomized, Double-blind, Multicenter, Phase III Study to Evaluate the Efficacy and Safety of Combination of Fimasartan/Rosuvastatin in Comparison to Each Component Administered Alone in Patients With Essential Hypertension and Dyslipidemia
Condition
Essential Hypertension, Dyslipidemia
Intervention (Drug)
Fimasartan and Rosuvastatin
Intervention (Drug)
Fimasartan
Intervention (Drug)
Rosuvastatin
Lead sponsor
Boryung Pharmaceutical Co., Ltd (class: industry)

Record details

Record id
cardio:ct-nct02166814
Content hash
6066152431ded0bed577f9774dbbaa4ba3c1d81e55de2844f2c99211aaed82d4